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ABSTRACT 
 
Bacterial infections are a threat to the modern healthcare because of the increase of the antibiotic resistance 
that many bacteria have developed during the history of antibiotics that began with the discovery of 
penicillin 1928. In order to respond to the accumulating resistance, novel antibiotics have to be discovered 
constantly. Therefore, there is an increasing need to exploit the ability of microorganisms to produce 
secondary metabolites with an antimicrobial effect. The current report addresses methods to activate silent 
genes coupled to the production of secondary metabolites. These procedures involve usage of microbial 
culture media with various composition, different culturing conditions such as high or low oxygen level as 
wells as addition of previously reported supplements that may trigger the expression of silent metabolic 
pathways for novel antibiotics. The different approaches used affected the metabolite production both by 
activating or suppressing the observed antimicrobial effects and possibly also resulted in the production of 
previously not detected substances. Some of the obtained substances will be further investigated in order to 
determine their structure and putative antimicrobial effects in more detail.        
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INTRODUCTION  
Infectious diseases caused by bacteria and fungi resistant to antibiotics are an increasingly severe threat to 
the modern standards of healthcare. The morbidity and mortality continue to rise worldwide as well as the 
costs coupled to the treatment of these infections. Finding treatments for these diseases has been and still are 
of great importance. In the early mid 20´th century the development of antimicrobial medicines experienced 
a breakthrough after Alexander Fleming found out that the mold Penicillium notatum produced a substance 
currently known as penicillin that inhibited the growth of Staphylococcus aureus  on plates (Fleming 1929). 
Along with the emerging use of antibiotics the bacteria became resistant to the treatments. As early as 1944, 
S. aureus was reported to make use of the enzyme β- lactamase to eliminate the effect of penicillin. To deal 
with this problem, scientists created semisynthetic variants of penicillin, for example methicillin, that S. 
aureus eventually also became resistant to (Neu 1992). Nowadays disease causing bacteria resistant to 
various antibiotics is a serious problem in many hospitals, not to mention infections caused by Methicillin 
Resistant S. aureus (MRSA). These bacteria are resistant to virtually all types of antibiotics (Enright et al. 
2002). Hence there is a critical need to find new antibiotics, and one of the places to investigate is once 
again among the secondary metabolites produced by microorganisms. One approach that is used in the 
search of new antibiotics is testing the influence of different culturing conditions such as culture media with 
different composition, aeration and so forth to investigate the impact on the production of secondary 
metabolites. Research conducted by systematically varying the culture conditions has shown that one 
talented microbial species can produce surprisingly many different compounds. This methodology is called 
One Strain- Many Compounds (OSMAC) (Bode et al. 2002). 
Another approach for the discovery of new antibiotics is to detect genes that are connected to the synthesis 
of bioactive compounds such as secondary metabolites, and then try to activate them in order to obtain more 
interesting substances (Ayuso-Sacido and Genilloud, 2005, Xie et al. 2014). There are still enormous 
amounts of bacterial species left to be explored and even more substances to discover from these species that 
may be used for various applications in both industry and healthcare.  
Examples of antibiotic- producing organisms  
Intense investigation in the last almost 80 years has resulted in the screening of many microorganisms. 
Particularly genera of filamentous bacteria and fungi have been attracting much interest in the search for 
active compounds. Also Pseudomonas, Bacillus and the cyanobacteria are included in the list of potential 
producers of valuable substances (Donadio et al., 2002). Frequently mentioned in antibiotic discovery 
related publications are species belonging to the phylum Actinobacteria. They are Gram- positive bacteria 
known to produce not only antibiotics but also metabolites active against cancer and suppressors of the 
immune system (Baltz 2008, Zotchev 2012). Of all antibiotics that were discovered in the years between 
1940 and 1960, 70-80% was isolated from Streptomyces species (Bérdy 2005, Bush 2010). Streptomycin, 
produced by Streptomyces griseus, is one example of an antibiotic that is produced by Actinobacteria spp. 
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Other examples of antibiotics produced by actinobacteria are Tetracycline, Erythromycin and Daptomycin 
(Mahajan and Balachandran 2012). Both actinobacteria of marine origin (reviewed by Manivasagana et al. 
2013, Zotchev 2012,) and terrestrial origin (reviewed by Kumar et al. 2013) have been revealed to produce 
antimicrobial substances against both Gram-positive and Gram-negative bacteria that are multi-drug 
resistant. Recent studies have been focused on rare actinobacteria also called non-streptomycetes in the 
search for novel secondary metabolites as reviewed by Tiwari and Gupta (2012).  
Genetic approach in the discovery of novel antimicrobial agents  
The enzyme families type I polyketide synthase (PKS-I), type II polyketide synthase (PKS-II), non-
ribosomal peptide synthetase (NRPS) and diterpene synthases (DTS) has been linked to the synthesis of 
secondary metabolites from different microorganisms (Ayuso-Sacido and Genilloud 2005, Xie et al. 
2014).These large enzymes are considered to be multifunctional, meaning that one single protein has the 
ability to generate various compounds.  PKS-I manufacture reduced polyketides, PKS-II produce aromatic 
polyketides and NRPS create non-ribosomal peptides. The fourth mentioned enzyme DTS generate 
diterpenoides (Xie et al. 2014). A recent report proposes a method to achieve metabolites from the 
respective enzymatic class by using primers targeted to the corresponding gene as a criterion which isolate 
to cultivate (Xie et al. 2014). After screening 100 strains of actinobacteria, the authors choose 16 strains that 
had the potential to produce all the four classes of natural products. One of them, a strain of Streptomyces 
griseus, was showcased to produce several metabolites from all these different classes of natural products.    
The advent of sequencing has facilitated the search of genes responsible of secondary metabolite production.  
Bentley et al. (2002) reported the whole genome sequencing of Streptomyces coelicolor and found out that 
its genome possess a large number of potentially interesting genes for antibiotic production. Baltz (2008) 
compiled the total genome sizes and compared that to the size of PKS-I/-II and NRPS- genes of several 
bacterial species. In addition to actinobacteria, species from the genus Pseudomonas showed big potential 
for antibiotic production due to its relatively large proportions of PKS- and NRPS-genes in their genomes.    
Activating silent genes 
Sequencing of Streptomyces species reveals that they do contain many genes coding for the enzymatic 
pathways for the synthesis of bioactive compound, but only a few of these end products were actually 
detected when the organism was cultured at standard laboratory conditions (Bentley et al. 2002). The silent 
genes can hold great potential to encode for enzymes that make novel antibiotics and several methods to 
activate these pathways have been reported. For example, by introducing mutations in gene rpoB which 
encode for the β- subunit in RNA polymerase, the production of secondary metabolites by some microbes 
increased (Ochi and Hosaka 2013). Other approach for activating genes involved in secondary metabolite 
expression is adding selected supplements that affect the relevant gene expression in the cultures. Rare earth 
elements such as Scandium have been shown to trigger the production of both certain enzymes and also the 
production of secondary metabolites in microorganisms (Inaoka and Ochi 2011). Triclosan is a formerly 
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used antimicrobial ingredient in toothpaste (which is still used in parts of the world) that recently has also 
been examined for its effect as a trigger of antibiotic production (Craney et al. 2012).   
As a defense mechanism, bacteria can use signaling substances as pheromones in a way called quorum 
sensing, that allows them to communicate with each other. Sufficient concentration of these pheromones can 
either activate or suppress genes encoding for enzymes involved in e.g. secondary metabolite production (de 
Kievit and Iglewski 2000). One example of signaling molecules that particularly Gram-negative bacteria use 
is N-Acylhomoserine lactones (AHLs), which chemical structure have been described (Yajima 2014). Gram- 
positive bacteria in contrariwise, use γ-butyrolactone (GBL) as signal substance (Takano et al. 2000).  
Culturing of talented bacterial isolates 
When the technologies that are known as high-throughput screening (HTS) were introduced in the beginning 
of 1990´s it was believed to revolutionize the search for new drugs (Persidis 1998). Older methods like 
fermentation and testing against target pathogens had to step aside for the modern techniques. Unfortunately 
HTS did not reach the expected success (Livermore 2011). Very few new antibiotics have been discovered 
since the antibiotic golden age in the 1940´s, and nowadays the majority of the current antibiotics are 
derivatives of the ones that were originally discovered as secondary metabolites of actinobacteria. Currently, 
it is believed that lots of the antibiotics that can be produced by actinobacteria are still left to be discovered. 
Research at companies and universities must only put more efforts and re-introduced screening of enough 
numbers actinobacteria with improved methods (Baltz 2008).  
Scope of this investigation   
In the current report, a few Gram-positive isolates of actinobacteria that hopefully might be used as putative 
antimicrobial agents were chosen for their potential ability to produce secondary metabolites. The choice of 
microbes for antibiotic research, nowadays, can be based on their genetic potential to produce metabolites. 
Genes that are linked to the production of metabolites can be screened in order to investigate if they are 
present within the organism. Sometimes these genes can be weakly expressed or silent when culturing in 
standard conditions. It is therefore desirable to try to switch on these genes using various culturing 
conditions (Baltz 2008).  
As a comparison, a representative of the Gram- negative bacterial species (Pseudomonas) belonging to the 
phylum Proteobacteria was included in the set of experiments. Previous research has shown that species 
from the genus Pseudomonas produce antibiotics against plant pathogens such as fungi (Raaijmakers et al. 
1997).  
The bacterial isolates were tested to see if the genes encoding for PKS-I, PKS-II, NRPS and DTS were 
present in their genome, followed by methods aimed to activate or enhance their potential for production of 
antimicrobial secondary metabolites.  The basic hypothesis was that when talented microorganisms are 
cultured in different conditions and with various supplements a change in antimicrobial activity may be 
detected similar to what have been observed by previous research efforts.  
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MATERIALS AND METHODS 
Growth media 
The following culture media reported by Bisht et al. (2013) with some modifications were used in this study: 
Arginine glycerol salt broth (AGS), Glucose soybean meal (GS) and Fermentation Medium 4 (FM4) but 
without glycerol. A commercial Vegetable Peptone Broth (VPB) was used as a standard medium to allow 
various comparisons. Afterwards, an additional medium denoted Glucose soy peptone (GSP), was composed 
on the basis of some other media. The media composition is presented in Table 1. Glycerol (25 ml, 50% 
w/v) was added to AGS medium after autoclaving. 
For the inhibition zone bioassay two different media were used: Vegetable Peptone Agar (VPA) and COR 
(Table 1). COR medium was composed as a mixture of three different media. At first, Mineral Medium 
(MM, Table 1) previously described by Stainer et al. (1966) with modifications by Pohanka et al. (2005) was 
made in 800 ml of deionized H2O. This medium was, afterwards, complemented by adding 100 ml each of 
the two other media: Tryptone broth (O) and Casamino Acids- Dextrose Broth (R, Table 1). When needed 
15 g agar was added to solidify the growth media. After autoclaving, 2 % (20 g/L) of glycerol was added to 
the mixture.   
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Table 1: Media composition 
Medium Composition (gram/liter H2O) 
AGS 1.0 L-arginine (SIGMA-ALDRICH), 1.0 K2HPO4(MERCK), 1.0 NaCl 
(SIGMA-ALDRICH), 0.5 MgSO4·7H2O (SIGMA-ALDRICH), 0.001 
CuSO4·5H2O (SIGMA-ALDRICH), 0.01 Fe2(SO4)3·6H2O (SIGMA-
ALDRICH) and 0.001 ZnSO4·H2O (MERCK) 
GS 10.0 glucose (VWR), 10.0 soybean meal (Grocery brand Risenta), 10.0 NaCl 
(SIGMA-ALDRICH ) and 1.0 CaCO3 (SIGMA-ALDRICH) 
VPB 15.0 Vegetable Peptone Broth (OXOID) 
FM 4 10.0 glucose (VWR), 10.0 soluble starch (SIGMA-ALDRICH), 2.5 corn steep 
liquor (SIGMA-ALDRICH), 5.0 peptone (BD), 2.0 yeast extract (BD), 1.0 
NaCl (SIGMA-ALDRICH) and 3.0 CaCO3 (SIGMA-ALDRICH) 
GSP 20.0 glucose (VWR), 10.0 soy peptone (BD), 10.0 NaCl (SIGMA-
ALDRICH) and 1.0 CaCO3 (SIGMA-ALDRICH)  
VPA 10.0 Vegetable Peptone Broth (OXOID), 15.0 agar (SIGMA-ALDRICH)  
MM 40 ml Na2HP04·KH2P04 (SIGMA-ALDRICH), 25 ml mineral stock A, 25 ml 
mineral stock B, 1.0 (NH4)2SO4 (SIGMA-ALDRICH), 20 glycerol (Stainer et 
al., 1966, Pohanka et al., 2005) 
O  10.0 Tryptone (BD), 1 L-Tryptophan (SIGMA-ALDRICH), 5.0 NaCl 
(SIGMA-ALDRICH) 
R  10.0 Casamino Acids (BD), 2.0 Dextrose (VWR), 1.25 K2HPO4 (SIGMA-
ALDRICH), 1.0 yeast extract (BD) 
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Bacterial isolates 
The different bacterial isolates were selected for their potential to produce secondary metabolites. The 
isolate identities and origin is shown in Table 2.  
 
Table 2: The identity of bacterial isolates and their origin  
Isolate 
denotation  
Isolate identity  Origin 
AV130 Streptomyces sp. Coffee plant 
GB 34:1 Nocardia sp. Geodia barretti (sponge) 
GB 43 Pseudomonas sp. Geodia barretti (sponge) 
T110 Streptomyces sp. Seaweed 
T339 Brevibacterium sp. Seaweed 
T306 Salinibacterium sp. Seaweed 
AV226:2 Serratia sp. Grass 
GB39 Mycobacterium sp.  Geodia barretti (sponge) 
GB59 Brevibacterium sp.  Geodia barretti (sponge) 
GB7 Bacillus sp. Geodia barretti (sponge) 
MF503 Serratia sp.  Plant material from field  
CCUG11104T Streptomyces griseus Reference strain* 
CCUG11110TT Streptomyces coelicolor  Reference strain* 
 
 
Screening for the presence of genes involved in secondary metabolism  
DNA was isolated from the bacterial isolates AV130, GB34:1, GB43, T110, T339, CCUG11104T and 
CCUG11110TT using FASTDNA SPIN kit for soil. The PCR primers targeting the four genes PKS-I, PKS-
II, NRPS and DTS are presented in Table 3 (Xie et al. 2014, Ayuso-Sacido and Genilloud, 2005). For the 
PCR reaction DreamTaq master mix (Thermofisher Scentific) was used together with forward and reverse 
primer with a final concentration of 0.4 µM each. The PCR program was as follows: initial melting at 95 ºC 
for 5 min, followed by 30 cycles with 94 ºC for 30 sec, 52 ºC for 30 sec and 72 ºC for 1 min, and finally an 
elongation step at 72 ºC for 7 min.  
 
 
 
 
* Obtained from Culture Collection, University of Gothenburg, Sweden (CCUG) 
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Table 3: Primers for PCR 
Gene Direction Primers 
PKS-1  Forward 5´TSAAGTCSAACATCGGBCA3´ 
PKS-1 Reverse 5´CGCAGGTTSCSGTACCAGTA3´ 
PKS-2  Forward 5´GGCAGCGGITTCGGCGGITTCCAG3′ 
PKS-2  Reverse 5´CGITGTTIACIGCGTAGAACCAGGCG3′ 
DTS  Forward 5´CGCTCAGTGCGGTSGAG3′ 
DTS  Reverse 5´GGIGAGGCGTGCCACTTGTC3′ 
NRPS  Forward 5´GCSTACSYSATSTACACSTCSGG3´ 
NRPS  Reverse 5´SASGTCVCCSGTSCGGTAS3´ 
 
 
Culturing conditions and media composition  
In the first experiment (experiment 1) the selected bacteria; AV130, GB34:1, GB43, T110, T339, 
CCUG11104T and CCUG11110T were all pre-cultured in a mixture of 80 % VPB (Table 1) and 20 % Malt 
Extract (15 g Malt Extract, (Difco Ltd) in 1 L deionized H2O) in order to obtain well growing inoculum. The 
cultures were incubated at 20 ºC on a rotary shaker (135 rpm) for 24 h. Fifteen ml of the pre-cultured 
bacteria were inoculated in 500 ml E-flasks, each containing 150 ml FM 4 (Table 1) and incubated at 20 ºC 
on a rotary shaker (210 rpm) for 6 days. For each isolate one baffled (high oxygen access) and one regular 
E-flask (low oxygen access) was used. After incubation overnight, one nylon tea bag containing 
approximately 5 grams of polymer resin Amberlite XAD16N (SIGMA-ALDRICH) was placed in each flask 
to allow the absorption of any produced secondary metabolites.  
The Amberlite bags were harvested at the end of cultivation and washed by deionized water to remove any 
bacterial cells attached to the bag. The accumulated metabolites were then extracted stepwise in tubes with 
20 ml methanol followed by 20 ml acetonitrile, and the extract was dried under nitrogen gas. The dried 
extracts containing secondary metabolites were later tested for their antimicrobial properties in a bioassay 
against non-pathogenic bacteria.  
 
For the second experiment (experiment 2), the bacterial isolates GB43, CCUG1110T, GB34:1 and GB59 
were inoculated in two 500 ml baffled flasks, each containing 100 ml of respectively the growth media AGS 
and GS (Table 1). The cultures were incubated, treated and extracted as described above with exception that 
they were incubated at 20 ºC on a rotary shaker (190 rpm).   
 
In the third experiment (experiment 3) the bacterial isolates GB43, GB34:1, T110 and CCUG11110T were 
grown in 150 ml of GSP medium (Table 1) with addition of the three various supplements: γ-butyrolactone 
S=G/C, B=C/G/T, Y=C/T, I=Inosine 
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GBL and ScCl3 (SIGMA-ALDRICH), and Triclosan (MERCK). The isolates GB34:1, T110 and 
CCUG11110T were inoculated in baffled flasks and isolate GB43 was inoculated in regular E-flasks. GBL 
(0.5 µM), Triclosan (1 µM) and ScCl3 (0.2 mM) were added each to one set of cultures. Controls were 
cultures without any additives. Cultures were in total incubated for a period of 9 days (20 ºC, 190 rpm). 
Three days after inoculation supplements were added and 24 h after the Amberlite bags. Extraction 
procedure was as described above.  
 
Zone inhibition assay 
The two test organisms Staphylococcus warneri and Pseudomonas resinovorans were diluted in VPB to a 
concentration of 5.0·10
5
 cfu/ml and 2.6·10
5
 cfu/ml respectively. The bacterial solutions were each spread 
onto two agar plates (Ø 14 cm), one containing the media VPA and the other one COR. Suspensions (10 µl) 
of the isolates AV130, GB34:1, GB43, T110, T339, CCUG11104T, CCUG11110T, T306, AV226:2, GB39, 
GB7 and MF503 were then spotted in a square pattern on the total four different plate/test organism 
combination and then incubated at 25 ºC for 3 days.  
 
Microtiter plate bioassay against non-pathogenic microorganisms   
The ability of extracts obtained in all culturing experiments to inhibit the growth of two tested organisms S. 
warneri and P. resinovorans was estimated in microtiter plate assay. Extracts from the experiment 1 
(varying oxygen levels) were dissolved in 5 ml methanol plus 5 ml acetonitrile, whereas extracts from 
experiments 2 (two culture media) and 3 (specific supplements) were dissolved in 2.5 ml methanol. Aliquots 
of extracts (100, 80, 60, 40, 20 and 10 µl) were distributed to the wells (96-wells microtiter plates) and dried 
overnight. Suspensions (100 µl) of S. warneri 3.0x10
4
 cfu/ml (experiment 1) and 3.3x10
5
 cfu/ml 
(experiment 2 and 3) and of P. resinovorans 4.3x10
4 
cfu/ml (experiment 1) and 2,9x10
5
 cfu/ml (experiment 
2 and 3) were added to the wells. Plates were cover with adhesive plastic covers (NUNC) and incubated at 
37 °C overnight. Inhibition of bacterial growth was estimated by eye using following scale: 0 – bacterial 
growth not inhibited at all; 1 – little inhibition of bacterial growth; 2 – intermediate inhibition of bacterial 
growth; 3 – full inhibition and no bacterial growth at all.  
High- Performance Liquid Chromatography (HPLC) 
In order to detect the possible metabolites with antimicrobial activity, the extracts collected from the 
supplement test (experiment 3) were separated by HPLC with gradient 10-95 % acetonitrile during 10 min 
with a flow of 10 ml min
-1
 (injection volume 1 ml, column HypersilGold, C-18, 5µm, 100 x 21.2 mm, and 
guard column 10 x 10 mm). Aliquots of the fractions (100µl) were transferred to seven identical replica 96-
well microtiter plates, and chromatograms showing the fractionated compounds absorbance at 210 nm 
wavelength were recorded. Solvents were, afterwards, evaporated in the fume cupboard.  
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Microtiter plate assay against pathogenic microorganisms 
Suspensions (100µl, approximately 10
4
 cfu/ml) of six different bacterial pathogens and one fungal pathogen 
were distributed into wells. The plates were incubated at 37 ºC overnight. Inhibition of bacterial growth was 
estimated as described above. 
LC-MS analysis of active fractions 
The fractions that showed the interesting activity profile against the pathogens were analyzed by using 
Liquid Chromatography- Mass Spectrometry (LC-MS). The column used was Accucore RP-MS (50 x 3 
mm, particle size 2.6 µm). The eluent consisted two parts: A (H2O, 0.2 % FA) and B (MeCN, 0.2 % FA). 
One microliter of the active fractions were injected and analyzed with the gradient of 10-95 % eluent during 
4 min, followed by 95 % eluent for 3 min, and ended with 10 % eluent for 3 min. The flow was set at 0.8 
ml/min. The substances were detected in the mass spectrometer Bruker maXis Impact, Q- TOF (electrospray 
ionization with positive ions), and compared against known microbial metabolites from the database 
Antibase.  
 
RESULTS 
 
PCR screening of genes for secondary metabolites 
Seven of the bacterial isolates in this report (AV130, GB34:1, GB43, T110, T339, CCUG11104T and 
CCUG11110T) were tested if they harbor genes that encode for secondary metabolites associated enzymes 
PKS-1, PKS-2, NRPS and DTS. A gel of the resulting PCR-products is shown in Figure 1. These results are 
converted into a gene grading scale that corresponds to the number of PCR products obtained from each 
bacterial isolates (Figure 2). For the bacterial isolate GB43 the results strongly indicate that is possesses all 4 
genes, and the bacterial isolate GB34:1 seems to have all genes with doubts concerning PKS-II. The gene 
encoding for DTS is present both in isolate CCUG11104T and T110, and probably also in the reference 
strain CCUG11110TT but not in isolate AV130. In the strain CCUG11104T the presence of PKS-II could be 
detected but not in the isolate T339. The remaining gene NRPS could be weakly detected in the isolates 
T339, T110 and AV130.  
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Figure 2: Genetic potential of the tested isolates estimated after converting the bands for PCR- products on 
the gel image in Figure 1. The following scale was used for conversion: 0- no PCR-product, 1- only one 
PCR-product, 2- two PCR-products, 3- three or more PCR-products.  
 
Zone inhibition assay  
The bacterial isolates AV130, GB34:1, GB43, T110, T339, CCUG11104T and CCUG11110T were cultured 
in baffled flasks at a relatively high speed on a rotary shaker for increased oxygen exposure. The results of 
the zone inhibition assay that was performed on plates with different substrates are shown in Figure 3 and 4. 
The bacterial isolate GB43 and two other isolates included in the test AV226:6 and MF503 showed 
inhibition zones against S. warneri on both COR and VPA plates. The bacterial isolate CCUG11110T also 
0 1 2 3 4 5 6 7 8 9 10 11 12 13
AV130
GB 34-1
GB 43
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CCUG11104T
CCUG11110T
Number of PCR products 
B
ac
te
ri
al
 is
o
la
te
s 
Gene score  
PKS-I
PKS-II
DTS
NRPS
Figure 1: Gel image of PCR products. L (ladder) 
A (PKS-II), B (DTS), C (PKS-I) and D (NRPS). 
1(AV130), 2 (GB34:1), 3 (GB43), 4 (T110), 5 
(T339) 6 (CCUG11104T), 7 (CCUGG11110T), 8 
(Negative control). 
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created an inhibition zone against S. warneri but only on the plate with COR. The isolate AV226:2 only 
showed a narrow inhibition zone against P. resinovorans (result not shown).     
 
 
 
 
 
 
 
 
 
Figure 3: Inhibition zone bioassay. 
Suspensions of the bacterial 
isolates (starting from the top left) 
AV226:2, T339, AV130, GB39, 
11104 T, GB34:1, GB7, 
CCUG11110T, GB43, MF503, 
T306 and T110 were spotted (10 
µl) on a COR plate with S. 
warneri as test organism. Plates 
were inspected after 72 h at 25 ºC. 
Figure 4: Inhibition zone 
bioassay. Suspensions of the 
bacterial isolates (starting from 
the top left) AV226:2, T339, 
AV130, GB39, 11104 T, GB34:1, 
GB7, CCUG11110T, GB43, 
MF503, T306 and T110 were 
spotted (10 µl) on a VPA plate 
with S. warneri as test organism. 
Plates were inspected after 72 h at 
25 ºC. 
 
18 
 
Influence of culturing conditions on production of secondary metabolites 
Experiment 1- Oxygen exposure  
The results of the 96-well microtiter plate bioassay with extracts from the cultures exposed to different 
levels of oxygen are shown in Figure 5. Bacterial isolate GB43 produced secondary metabolites that inhibit 
the growth of both test organisms S. warneri and P. resinovorans when it was cultivated in non-baffled 
flasks. Higher concentration of extracts of the isolate GB34:1 obtained after cultivation in baffled flasks also 
inhibits the growth of both test organisms. Extracts from bacterial isolate CCUG11110T cultivated in 
baffled flasks displayed activity against S. warneri at all tested concentrations.   
 
 
Test organism S. warneri 
        Regular E-
flasks           µl              
 
100 100 80 80 60 60 40 40 20 20 10 10 
AV130 0 0 0 0 0 0 0 0 0 0 0 0 
GB 34:1 3 3 2 2 1 1 0 0 0 0 0 0 
GB 43 3 3 3 3 3 3 3 3 3 3 3 3 
T110 2 2 1 1 1 1 1 1 0 0 0 0 
T339 0 0 0 0 0 0 0 0 0 0 0 0 
CCUG11104 T 0 0 0 0 0 0 0 0 0 0 0 0 
CCUG11110T 1 1 0 0 0 0 0 0 0 0 0 0 
 
Test organism P. resinovorans 
       Regular E-
flasks           µl              
 
100 100 80 80 60 60 40 40 20 20 10 10 
AV130 0 0 0 0 0 0 0 0 0 0 0 0 
GB 34:1 3 3 1 2 0 0 0 0 0 0 0 0 
GB 43 3 3 3 3 3 3 3 3 3 3 3 3 
T110 0 0 0 0 0 0 0 0 0 0 0 0 
T339 0 0 0 0 0 0 0 0 0 0 0 0 
CCUG11104 T 0 0 0 0 0 0 0 0 0 0 0 0 
CCUG11110T 0 0 0 0 0 0 0 0 0 0 0 0 
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Test organism S. warneri 
Baffled flasks           µl              
 
100 100 80 80 60 60 40 40 20 20 10 10 
AV130 3 3 2 2 1 1 0 0 0 0 0 0 
GB 34:1 3 3 1 1 0 0 0 0 0 0 0 0 
GB 43 1 1 0 0 0 0 0 0 0 0 0 0 
T110 3 3 3 3 2 2 2 2 0 0 0 0 
T339 0 0 0 0 0 0 0 0 0 0 0 0 
CCUG11104 T 0 0 0 0 0 0 0 0 0 0 0 0 
CCUG11110T 3 3 3 3 3 3 3 3 2 2 1 1 
 
Test organism P. resinovorans 
       Baffled flasks           µl        
  100 100 80 80 60 60 40 40 20 20 10 10 
AV130 0 0 0 0 0 0 0 0 0 0 0 0 
GB 34:1 3 3 3 3 0 0 0 0 0 0 0 0 
GB 43 0 0 0 0 0 0 0 0 0 0 0 0 
T110 2 2 2 2 2 2 2 2 1 1 0 0 
T339 0 0 0 0 0 0 0 0 0 0 0 0 
11104 T 1 1 1 1 0 0 0 0 0 0 0 0 
CCUG11110T 0 0 0 0 0 0 0 0 0 0 0 0 
 
Figure 5: Inhibition of the S. warneri and P. resinovorans growth by extracts of isolates cultured with 
varying oxygen access. The activity was graded with following scale: 0 – bacterial growth not inhibited at 
all; 1 – little inhibition of bacterial growth; 2 – intermediate inhibition of bacterial growth; 3 – full 
inhibition, no bacterial growth at all. 
 
Experiment 2- Different growth media composition 
In general, only the extracts of isolates CCUG11110T and GB43 inhibited the growth of both test 
organisms. The bacterial isolate CCUG11110T produced metabolites that inhibited the growth of both test 
organisms when cultivated in the medium AGS whereas metabolites from GB43 cultured in AGS and GS 
correspondingly inhibited the growth of test organisms S. warneri and P. resinovorans (Figure 6). 
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Test organism S. warneri             µl           
  
100 100 80 80 60 60 40 40 20 20 10 10 
AGS GB43 3 3 3 3 3 3 2 2 2 2 1 1 
  CCUG11110T 3 3 3 3 3 3 3 2 1 1 1 1 
  GB34:1 1 1 1 1 1 1 1 0 0 0 0 0 
  GB59 0 0 0 0 0 0 0 0 0 0 0 0 
GS GB43 3 3 3 3 3 3 3 3 0 0 0 0 
  CCUG11110T 1 1 0 0 0 0 0 0 0 0 0 0 
  GB34:1 0 0 0 0 0 0 0 0 0 0 0 0 
  GB59 0 0 0 0 0 0 0 0 0 0 0 0 
              
Test organism  
P. resinovorans             µl           
  
100 100 80 80 60 60 40 40 20 20 10 10 
AGS GB43 3 3 3 3 3 3 3 3 3 3 0 0 
  CCUG11110T 2 2 1 1 1 1 1 1 1 1 1 1 
  GB34:1 0 0 0 0 0 0 0 0 0 0 0 0 
  GB59 0 0 0 0 0 0 0 0 0 0 0 0 
GS GB43 3 3 3 3 3 3 2 3 0 0 0 0 
  CCUG11110T 0 0 0 0 0 0 0 0 0 0 0 0 
  GB34:1 0 0 0 0 0 0 0 0 0 0 0 0 
  GB59 0 0 0 0 0 0 0 0 0 0 0 0 
 
Figure 6: Inhibition of the S. warneri and P. resinovorans growth by extracts of isolates cultured in different 
culture media. The activity was graded with following scale: 0 – bacterial growth not inhibited at all; 1 – 
little inhibition of bacterial growth; 2 – intermediate inhibition of bacterial growth; 3 – full inhibition, no 
bacterial growth at all. 
Experiment 3- Culturing in the presence of various supplements  
The bacterial isolate T110 produced metabolite(s) active against S. warneri after being exposed to the 
supplements compared to control (Figure 7). The addition of ScCl3 down-regulated the activity of the 
bacterial isolates GB34:1 against S. warneri (Figure 7), and the same observation was noticed for bacterial 
isolate T110 against the other test organism P. resinovorans (Figure 7). Also GBL deactivated the 
metabolites from T110 whereas Triclosan triggered the activity against P. resinovorans (Figure 7).    
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Test organism S. warneri             µl           
    100 100 80 80 60 60 40 40 20 20 10 10 
CCUG11110T Control 3 3 3 3 3 3 3 3 2 2 1 1 
  Triclosan 3 3 3 3 3 3 3 3 3 3 3 3 
  ScCl3 3 3 3 3 3 3 2 2 1 1 1 0 
  GBL 3 3 3 3 3 3 3 3 1 1 1 1 
GB34:1 Control 3 3 3 3 2 2 2 2 0 0 0 0 
  Triclosan 3 3 3 3 3 3 3 3 3 3 3 3 
  ScCl3 0 0 0 0 0 0 0 0 0 0 0 0 
  GBL 3 3 3 3 3 3 3 2 0 0 0 0 
T110 Control 2 2 1 1 1 0 0 0 0 0 0 0 
  Triclosan 3 3 3 3 3 3 3 3 3 3 2 2 
  ScCl3 3 3 3 3 3 3 3 3 3 3 3 3 
  GBL 3 3 3 3 3 3 3 3 3 3 3 2 
GB43 Control 3 3 3 3 3 3 3 3 1 1 0 0 
  Triclosan 3 3 3 3 3 3 3 3 3 3 3 3 
  ScCl3 3 3 3 3 3 3 3 3 0 0 0 0 
  GBL 3 3 3 3 3 3 3 3 0 0 0 0 
 
Test organism P. resinovorans             µl           
    100 100   80 60 60 40 40 20 20 10 10 
CCUG11110T Control 3 3 3 3 3 3 3 3 3 3 2 2 
  Triclosan 3 3 3 3 3 3 3 3 3 3 3 3 
  ScCl3 3 3 3 3 3 3 2 1 0 0 0 0 
  GBL 3 3 3 3 3 3 3 3 3 3 1 1 
GB34:1 Control 3 3 3 3 3 3 3 3 1 1 0 0 
  Triclosan 3 3 2 2 2 2 2 1 0 0 0 0 
  ScCl3 1 1 0 0 0 0 0 0 0 0 0 0 
  GBL 3 3 3 3 3 3 3 3 3 3 0 0 
T110 Control 1 1 0 0 0 0 0 0 0 0 0 0 
  Triclosan 3 3 3 3 3 3 3 3 0 0 0 0 
  ScCl3 0 0 0 0 0 0 0 0 0 0 0 0 
  GBL 0 0 0 0 0 0 0 0 0 0 0 0 
GB43 Control 3 3 3 3 3 3 3 3 3 3 0 0 
  Triclosan 3 3 3 3 3 3 3 3 3 3 0 0 
  ScCl3 3 3 3 3 3 3 3 3 3 3 0 0 
  GBL 3 3 3 3 3 3 3 3 3 3 0 0 
 
Figure 7: Inhibition of the S. warneri and P. resinovorans growth by extracts of isolates cultured on GPS 
medium with different supplements. The activity was graded with following scale: 0 – bacterial growth not 
inhibited at all; 1 – little inhibition of bacterial growth; 2 – intermediate inhibition of bacterial growth; 3 – 
full inhibition, no bacterial growth at all. 
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Microtiter plate assay against pathogenic organisms  
The HPLC separated fractions of extracts from the supplement experiment were tested against several 
pathogenic microorganisms. The additions of Triclosan to the culture with bacterial isolate CCUG11110T 
resulted in two new substances active against pathogen F (red encircled activity area Figure 8).  The active 
substance (blue encircled activity area Figure 8) was established to be Triclosan.  
Separation of extracts produced by the bacterial isolate T110 and T110 supplemented with ScCl3 both 
resulted in detecting antimicrobial affect. However, the retention time for active fractions was different for 
these two samples suggesting production of two different active metabolites (orange and purple encircled 
activity area Figure 9). 
 
 
Figure 8: HPLC chromatograms of the isolate CCUG11110T extracts cultured without supplements (top) 
and with addition of Triclosan (bottom) and corresponding activity against a panel of pathogenic 
microorganisms. The green encircled fractions in the top chromatogram show activity against pathogen G. 
The blue encircled fractions in bottom chromatogram were active against almost all of the test pathogens 
and the two red encircled fractions were only active against pathogen F. The remaining detected activity was 
most likely due to cyclic dipeptides derived from media components.      
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Figure 9: HPLC chromatograms of the isolate T110 extracts cultured without supplements (top) and with 
addition of ScCl3 (bottom) and corresponding activity against a panel of pathogenic microorganisms. The 
orange and purple circles show the activity against the test organism F at different retention time for top and 
bottom chromatogram. The remaining detected activity was most likely due to cyclic dipeptides derived 
from media components.  
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DISCUSSION  
 
The aim of this study was to trigger several bacterial isolate to produce different secondary metabolites, 
hopefully also including novel compounds that may be used as future antibiotics as a countermeasure to the 
increasing antibiotic resistance among an alarmingly large proportion of microbial pathogens. Three 
experiments were performed, in which the influence of different oxygen levels, different media composition 
and adding different supplements to the cultures on the production of active metabolites was tested. The 
hypothesis was that a change in activity against the test organisms should be distinguished if it is as agreed 
with similar research from the literature (Bode et al. 2002, Craney et al. 2012, de Kievit and Iglewski 2000, 
Inaoka and Ochi 2011). Overall it seemed that the experiment with varying supplements added to the 
cultures generated the most powerful antimicrobial effect for the highest number of tested isolates. 
Especially, addition of Triclosan yielded a number of active substances in the extracts of all bacterial 
isolates. One of the detected substances was established as Triclosan (Figure 8) after LC- MS analysis and 
molecular weight comparison with substances available for comparison in the database Antibase. Also the 
determination of substances by LC-MS revealed the higher diversity of produced secondary metabolites. It 
can confirm the approach referred to as OSMAC (Bode et al. 2002): that one microorganism is capable of to 
generate several active metabolites under varying culture conditions.  
The reference isolate CCUG11110T, denotation for Streptomyces coelicolor, showed its potential to produce 
antibiotics, particularly in the experiments using supplements (Figure 7). Similar experiments in reviews 
have shown the same outcome in successful activity against several test organisms (Craney et al. 2012, 
Kawai et al. 2007 and Takano et al. 2000). Concerning non-Streptomyces and their optimistically capacity to 
produce novel antibiotics (Tiwari and Gupta 2012), bacterial isolate GB34:1 (representing Nocardia sp) 
displayed promising antibiotic production in the current research both in terms of the detected genes coupled 
to the secondary metabolism (Figure 2) and activity against the test organisms (Figure 5 and 7). It must be 
further investigated what kind of active metabolites were produced by this organism.      
The initial test consisted of performing PCRs of four genes (PKS-1, PKS-2, NRPS and DTS) encoding for 
enzymes that have been shown to be involved in the production of secondary metabolites. Isolate GB43, 
belonging to the genus Pseudomonas, was tested positive for all four genes. Its potential was also reflected 
in the bioassays. Metabolites produced by the isolate GB43 showed activity against both S. warneri and P. 
resinovorans in all bioassays except in the inhibition zone test against P. resinovorans and also in the 
microtiter plate inhibition assay cultured in baffled flasks (Figure 5). Since none of the isolates apart from 
one (AV226:2, figure not shown) were inhibiting the growth of P. resinovorans in the inhibition zone test, it 
can be concluded that the growth of the test organism may have been too strong or simply that no effective 
antibiotics against P. resinovorans could be found. Based on the results from the bioassay of the extracts 
produced by this isolate that originated from cultures grown at different oxygen level, one can conclude that 
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Pseudomonas sp. apparently grows well in the presence of high oxygen level but are not able to produce 
antimicrobial metabolites.  
GBL used in this report as a supplement has a similar core structure as the family of signal molecule AHL. 
Mostly gram-negative bacteria use AHL in the quorum-sensing signaling (Yajima, A. 2014) whereas many 
Gram-positive bacteria use GBLs as signaling molecules for regulation of antibiotic production (Takano et 
al. 2000). It is consistent that isolate GB43, which is a Gram-negative bacterium, were activated in the 
production of metabolites in the supplement experiment after DHM- furanone was added to the culture.  
DHM- furanone activated the secondary metabolite production for all bacterial isolates except T110 against 
P. resinovorans. Both that absence of activity for bacterial isolate T110 and the poor activity of all isolates 
against P. resinovorans in general could possibly be explained by that P. resinovorans may have used a 
quorum-sensing mechanism that protected its growth in the presence of active metabolites.  Pseudomonas 
species, like other Gram-negative bacteria, are also known to use efflux pumps to effectively reject the 
added antimicrobial agents, which had led to the enormous problems with nosocomial infections caused by 
antibiotic resistant bacteria (Köhler et al. 1997, Nikaido 1996).      
 
CONCLUSION AND FUTURE PERSPECTIVES  
Different culturing conditions and added supplements positively affected the cultivated bacterial isolates in a 
way that the production of secondary metabolites with antimicrobial properties was in general enhanced.   
However, the experiments have to be repeated in order to obtain more reliable result. Also, more various 
culture media and culture conditions should be included to clearer detect differences. The substances that 
were separated after the supplement experiments will be further investigated by Nuclear Magnetic 
Resonance (NMR) to closer elucidate their chemical structures.  If they prove to be novel they will undergo 
additional tests such as for example Minimum Inhibitory Concentration (MIC) that allows to established the 
minimal concentration of the compound, at which it totally inhibit the growth of tested pathogen. 
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